Takeda officer reports 57,580 ADS holdings

Q: What insider position does Shannon Elaine Mary hold at Takeda (TAK)?

Shannon Elaine Mary is Takeda’s Global Quality Officer. The Form 3 filing identifies her as an officer, not a director or 10% owner, and discloses her initial beneficial ownership in American Depositary Shares and restricted stock units of the company.

Q: How many Takeda (TAK) American Depositary Shares does Shannon Elaine Mary report?

She reports beneficial ownership of 57,580 American Depositary Shares. This amount includes shares underlying restricted stock units, reflecting her total direct position reported as of the Form 3 filing date, without indicating any new purchase or sale transaction.

Q: How many restricted stock units does Shannon Elaine Mary hold in Takeda (TAK)?

Her reported holdings include 27,146 restricted stock units (RSUs). Each RSU represents a contingent right to receive one American Depositary Share of Takeda, contributing to the total 57,580 ADS position disclosed in the ownership report.

Q: What is the vesting schedule for Shannon Elaine Mary’s Takeda (TAK) RSUs?

The 27,146 RSUs vest in three installments: 13,144 shares on July 1, 2026, 8,796 shares on July 1, 2027, and 5,206 shares on July 1, 2028. Each vested RSU will convert into one American Depositary Share.

Q: Does the Takeda (TAK) Form 3 show insider buying or selling by Shannon Elaine Mary?

The Form 3 is an initial ownership report and does not show a buy or sell transaction. It simply discloses Shannon Elaine Mary’s existing holdings of American Depositary Shares and restricted stock units at the time of the filing.

Takeda Pharmaceutical Global Quality Officer Shannon Elaine Mary reported beneficial ownership of 57,580 American Depositary Shares.

Accepted by SEC EDGAR 03/18/2026 - 06:13 AM EDT

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Takeda Pharmaceutical Global Quality Officer Shannon Elaine Mary reported beneficial ownership of 57,580 American Depositary Shares. This filing is an initial ownership report, not a new buy or sell transaction.

The holding includes 27,146 restricted stock units, each equal to one ADS, vesting in tranches on July 1, 2026 (13,144 shares), July 1, 2027 (8,796 shares) and July 1, 2028 (5,206 shares).

Insider Trade Summary

Holdings reported, no transactions

Holdings

Insider Shannon Elaine Mary

Role Global Quality Officer

Type	Security	Shares	Price	Value
Holding	American Depositary Shares	--	--	--

Holdings: American Depositary Shares — 57,580 shares (Direct)

Footnotes (1)

F1. Includes 27,146 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest on the following schedule: July 1, 2026 (13,144 shares), July 1, 2027 (8,796 shares) and July 1, 2028 (5,206 shares).

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider position does Shannon Elaine Mary hold at Takeda (TAK)?

Shannon Elaine Mary is Takeda’s Global Quality Officer. The Form 3 filing identifies her as an officer, not a director or 10% owner, and discloses her initial beneficial ownership in American Depositary Shares and restricted stock units of the company.

How many Takeda (TAK) American Depositary Shares does Shannon Elaine Mary report?

She reports beneficial ownership of 57,580 American Depositary Shares. This amount includes shares underlying restricted stock units, reflecting her total direct position reported as of the Form 3 filing date, without indicating any new purchase or sale transaction.

How many restricted stock units does Shannon Elaine Mary hold in Takeda (TAK)?

Her reported holdings include 27,146 restricted stock units (RSUs). Each RSU represents a contingent right to receive one American Depositary Share of Takeda, contributing to the total 57,580 ADS position disclosed in the ownership report.

What is the vesting schedule for Shannon Elaine Mary’s Takeda (TAK) RSUs?

The 27,146 RSUs vest in three installments: 13,144 shares on July 1, 2026, 8,796 shares on July 1, 2027, and 5,206 shares on July 1, 2028. Each vested RSU will convert into one American Depositary Share.

Does the Takeda (TAK) Form 3 show insider buying or selling by Shannon Elaine Mary?

The Form 3 is an initial ownership report and does not show a buy or sell transaction. It simply discloses Shannon Elaine Mary’s existing holdings of American Depositary Shares and restricted stock units at the time of the filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Shannon Elaine Mary

(Last)

(First)

(Middle)

45-55 HAYDEN AVENUE

(Street)

LEXINGTON

MASSACHUSETTS

02421

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
TAKEDA PHARMACEUTICAL CO LTD [ TAK ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Global Quality Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
American Depositary Shares	57,580⁽¹⁾	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)

Explanation of Responses:

1. Includes 27,146 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest on the following schedule: July 1, 2026 (13,144 shares), July 1, 2027 (8,796 shares) and July 1, 2028 (5,206 shares).

Remarks:

Exhibit 24 Power of Attorney

	/s/ Max Heuer, by power of attorney, for Elaine Shannon	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR